rs199543866

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6

The NM_001413023.1(RECQL4):​c.-764C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00115 in 1,612,326 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00077 ( 0 hom., cov: 34)
Exomes 𝑓: 0.0012 ( 0 hom. )

Consequence

RECQL4
NM_001413023.1 5_prime_UTR_premature_start_codon_gain

Scores

11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:8B:2

Conservation

PhyloP100: -1.98
Variant links:
Genes affected
RECQL4 (HGNC:9949): (RecQ like helicase 4) The protein encoded by this gene is a DNA helicase that belongs to the RecQ helicase family. DNA helicases unwind double-stranded DNA into single-stranded DNAs and may modulate chromosome segregation. This gene is predominantly expressed in thymus and testis. Mutations in this gene are associated with Rothmund-Thomson, RAPADILINO and Baller-Gerold syndromes. [provided by RefSeq, Jan 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.023060977).
BP6
Variant 8-144517096-G-A is Benign according to our data. Variant chr8-144517096-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 239755.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=8}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RECQL4NM_004260.4 linkc.308C>T p.Pro103Leu missense_variant Exon 4 of 21 ENST00000617875.6 NP_004251.4 O94761

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RECQL4ENST00000617875.6 linkc.308C>T p.Pro103Leu missense_variant Exon 4 of 21 1 NM_004260.4 ENSP00000482313.2 O94761

Frequencies

GnomAD3 genomes
AF:
0.000775
AC:
118
AN:
152268
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000555
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00131
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000604
AC:
149
AN:
246720
Hom.:
0
AF XY:
0.000572
AC XY:
77
AN XY:
134654
show subpopulations
Gnomad AFR exome
AF:
0.000328
Gnomad AMR exome
AF:
0.000174
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000233
Gnomad NFE exome
AF:
0.00115
Gnomad OTH exome
AF:
0.000834
GnomAD4 exome
AF:
0.00119
AC:
1735
AN:
1460058
Hom.:
0
Cov.:
31
AF XY:
0.00112
AC XY:
810
AN XY:
726302
show subpopulations
Gnomad4 AFR exome
AF:
0.000269
Gnomad4 AMR exome
AF:
0.000201
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000115
Gnomad4 NFE exome
AF:
0.00148
Gnomad4 OTH exome
AF:
0.00106
GnomAD4 genome
AF:
0.000775
AC:
118
AN:
152268
Hom.:
0
Cov.:
34
AF XY:
0.000632
AC XY:
47
AN XY:
74386
show subpopulations
Gnomad4 AFR
AF:
0.000555
Gnomad4 AMR
AF:
0.000327
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000941
Gnomad4 NFE
AF:
0.00131
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000909
Hom.:
0
Bravo
AF:
0.000706
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000714
AC:
6
ExAC
AF:
0.000614
AC:
74
EpiCase
AF:
0.00115
EpiControl
AF:
0.00101

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:8Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:4
Jun 05, 2024
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Identified without a second RECQL4 variant in a patient with clinical features of Rothmund-Thomson syndrome and with a missense RECQL4 variant in a patient with complex craniosynostosis (PMID: 12734318, 32139749); Observed heterozygous in a patient with sporadic pancreatic cancer and with a second RECQL4 variant in a patient with osteosarcoma (PMID: 32659497, 32191290); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 30680959, 32139749, 32659497, 37731390, 35591945, 12734318, 32191290) -

Oct 20, 2016
Eurofins Ntd Llc (ga)
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 18, 2021
AiLife Diagnostics, AiLife Diagnostics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 03, 2021
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Baller-Gerold syndrome Uncertain:1Benign:1
May 28, 2019
Mendelics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Uncertain:1
Oct 14, 2021
Genetic Services Laboratory, University of Chicago
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

DNA sequence analysis of the RECQL4 gene demonstrated a sequence change, c.308C>T, in exon 4 that results in an amino acid change, p.Pro103Leu. This sequence change has been previously described in an individual with RECQL4-related disorder (PMID: 12734318). This sequence change has been described in the gnomAD database with a low frequency of 0.11% in the non-Finnish European subpopulation (dbSNP rs199543866). The p.Pro103Leu change affects a poorly conserved amino acid residue of the RECQL4 protein. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD) provide contradictory results for the p.Pro103Leu substitution. Due to insufficient evidence and the lack of functional studies, the clinical significance of the p.Pro103Leu change remains unknown at this time. -

Inborn genetic diseases Uncertain:1
May 31, 2022
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.308C>T (p.P103L) alteration is located in exon 4 (coding exon 4) of the RECQL4 gene. This alteration results from a C to T substitution at nucleotide position 308, causing the proline (P) at amino acid position 103 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Rothmund-Thomson syndrome type 2 Uncertain:1
Aug 09, 2024
St. Jude Molecular Pathology, St. Jude Children's Research Hospital
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The RECQL4 c.308C>T (p.Pro103Leu) missense change has a maximum subpopulation frequency of 0.12% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). In silico tools predict a benign effect of this variant on protein function, but to our knowledge these predictions have not been confirmed by functional assays. This variant has been reported in an individual meeting diagnostic criteria for Rothmund-Thomson syndrome who did not have a second pathogenic variant in RECQL4 identified (PMID: 12734318). In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. -

Hereditary cancer-predisposing syndrome Benign:1
Dec 22, 2021
Sema4, Sema4
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: curation

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
1.4
DANN
Benign
0.86
DEOGEN2
Benign
0.053
T
FATHMM_MKL
Benign
0.055
N
LIST_S2
Benign
0.70
T
M_CAP
Benign
0.0028
T
MetaRNN
Benign
0.023
T
PrimateAI
Benign
0.33
T
Sift4G
Benign
0.16
T
Polyphen
0.75
P
Vest4
0.10
MVP
0.75
GERP RS
-3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.034
gMVP
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199543866; hg19: chr8-145742480; COSMIC: COSV105873970; COSMIC: COSV105873970; API